Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18

Abstract Before 2016, human papillomavirus (HPV) vaccination was recommended on a 3-dose schedule. However, many vaccine-eligible US females received fewer than 3 doses, which provided an opportunity to evaluate the real-world vaccine effectiveness (VE) of 1, 2, and 3 doses. We analyzed data on cerv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of epidemiology 2020-04, Vol.189 (4), p.265-276
Hauptverfasser:	Johnson Jones, Michelle L, Gargano, Julia Warner, Powell, Melissa, Park, Ina U, Niccolai, Linda M, Bennett, Nancy M, Griffin, Marie R, Querec, Troy, Unger, Elizabeth R, Markowitz, Lauri E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adenocarcinoma in Situ - prevention & control Adenocarcinoma in Situ - virology Adolescent Adult Cervical cancer Cervical Intraepithelial Neoplasia - prevention & control Cervical Intraepithelial Neoplasia - virology Confidence intervals Female Human papillomavirus Human papillomavirus 16 - isolation & purification Human papillomavirus 18 - isolation & purification Humans Immunization Lesions Papillomavirus Vaccines - administration & dosage Population Surveillance Regression analysis Regression models Schedules Statistical analysis Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology Vaccination Vaccine efficacy Vaccines Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!